Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01448135 · ClinicalTrials.gov registry record · NA

Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral Feeding Formula Versus a Standard Formula In Multiple Intensive Care Unit Settings

A NA study of Critical Illness and Enteral Feeding, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT01448135 is a NA study of Critical Illness and Enteral Feeding that has completed, run by Columbia University. The registered enrollment target is 50 participants, below the 3,138-participant average among 91 other Critical Illness trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01448135, a NA study of Critical Illness and Enteral Feeding, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this pilot study is to assess the efficacy, safety and tolerance profile of the enteral feeding product VITAL AF (a semi-elemental, high protein, and high omega-3 fish oil) when compared to Osmolite 1.2, a standard feeding product in critically ill and/or post surgical patients in the intensive care unit (ICU). If enough patients are recruited, inferences about impact on outcomes may also be drawn.

Interventions

  • OTHER VITAL AF
  • OTHER Osmolite 1.2

Study Locations (1)

New York

  • NewYork-Presbyterian Hospital at Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2011-10
Est. Completion 2014-11
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT01448135

The ClinicalTrials.gov registry entry for NCT01448135 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,138-participant average among 91 other Critical Illness trials with a reported enrollment target (98% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which VITAL AF is the first listed.

NCT01448135 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01448135 about?

NCT01448135 is a clinical study titled "Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral Feeding Formula Versus a Standard Formula In Multiple Intensive Care Unit Settings". The purpose of this pilot study is to assess the efficacy, safety and tolerance profile of the enteral feeding product VITAL AF (a semi-elemental, high protein, and high omega-3 fish oil) when compared to Osmolite 1.2, a standard feeding product in critically ill and/or post surgical patients in the...

What is the current status of trial NCT01448135?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2011-10. Estimated completion is 2014-11.

What conditions does trial NCT01448135 study?

This clinical trial studies the following conditions: Critical Illness, Enteral Feeding.

What interventions are being tested in trial NCT01448135?

The interventions under investigation include: VITAL AF (OTHER), Osmolite 1.2 (OTHER).

Who is sponsoring clinical trial NCT01448135?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01448135 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.